Certified by Founder
Lodge
Opsera
start up
United States
- Palo Alto, CA
- 05/10/2023
- Series A
- $12,000,000
Opsera is Continuous Orchestration for modern DevOps teams.
Customize and automate any CI/CD toolchain, build declarative pipelines, and view unified analytics and logs across your entire software delivery process. Opsera’s platform allows you the freedom to choose your own DevOps stack — with zero scripting involved.
With Opsera, you can automate any stack, build pipelines for any app, and deploy anywhere. Opsera accelerates best-practice CI/CD adoption so software teams can deliver software faster, safer, and smarter.
- Industry Software Development
- Website https://www.opsera.io/
- LinkedIn https://www.linkedin.com/company/opsera/about/
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)